Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Pelles Sharon
23 anos de experiência
Clínica certificada :
| Israel | Turquia | Áustria | |
| Remoção de cancro do cólon | de $22,500 | de $14,400 | de $20,000 |
| Resseção retal | de $24,500 | de $10,250 | de $21,000 |
| Colectomia (resseção do intestino grosso) | de $20,500 | de $6,912 | de $22,000 |
| Mesorrectumectomia robótica total | - | de $14,500 | - |
| Mesorrectomomia laparoscópica | - | de $9,500 | - |
A Bookimed não adiciona taxas extras aos preços de Remoção de cancro do cólon. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais em Remoção de cancro do cólon e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de Remoção de cancro do cólon.
A Clínica Assuta é o maior centro médico privado de Israel. O hospital especializa-se em oncologia, ortopedia, neurocirurgia, cirurgia cardíaca e tratamento de infertilidade. 13% de todas as operações no país são realizadas na Assuta, o que a torna um centro cirúrgico líder.
Pela qualidade e segurança no tratamento, o hospital recebeu a acreditação americana da Joint Commission International.
Anualmente, os médicos da rede Assuta realizam mais de 92.000 operações, 685.000 procedimentos diagnósticos e 16.000 ciclos de FIV.
A Dra. Pelles Sharon é especialista no tratamento do cancro do cólon no Sourasky Medical Center, combinando perícia cirúrgica com técnicas avançadas como HIPEC e imunoterapia.
Especialista líder em oncologia de sarcoma e óssea no Centro Médico Sourasky, com mais de 25 anos de experiência especializada.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Top colon cancer specialists in Israel include world-recognized surgical oncologists at JCI-accredited centers. These experts specialize in robotic-assisted resections and HIPEC. Many hold board certifications from the USA or Europe. They lead major departments at Sourasky, Hadassah, and Sheba Medical Centers.
Bookimed Expert Insight: Data shows a high concentration of international training among Israel's top colorectal surgeons. For example, Dr. Riad Hadad specialized in oncology at the University of Toronto. Dr. Pelles Sharon trained at the Royal Marsden in London. This global exposure allows them to implement the latest Western protocols locally.
Patient Consensus: Patients note that Israeli hospitals prioritize minimally invasive techniques. Many were surprised by short recovery times of 3 to 5 days. They highlight the benefit of multidisciplinary teams providing quick access for complex colorectal cases.
International patients typically choose their own surgeon when traveling to Israel for colon cancer removal. While the public system assigns doctors based on availability, private treatment packages allow direct selection of specialists with international training from institutions like the University of Toronto and Royal Marsden.
Bookimed Expert Insight: Data shows that top-tier gastrointestinal surgeons in Israel often hold dual expertise in both surgery and research. For example, Dr. Riad Hadad at Assuta has authored over 60 scientific publications, while Dr. Pelles Sharon at Sourasky Medical Center leads clinical trials. This combination of hands-on surgical skill and academic involvement often leads to more personalized treatment protocols for complex colon cancer cases.
Patient Consensus: Patients note that in the public system, the surgeon you get is often the 'luck of the draw' based on the weekly schedule. To ensure a specific senior expert handles their case, many prefer the private route where they can pick their doctor before arrival.
Israeli doctors utilize minimally invasive laparoscopy and robotic-assisted surgery as the primary standards for colon cancer. These techniques allow for precise tumor removal through small incisions. These methods help patients achieve faster recovery times and shorter hospital stays compared to traditional open procedures.
Bookimed Expert Insight: Data shows that top Israeli surgeons often hold dual expertise in both surgical oncology and radiotherapy. For instance, Dr. Auala Hubert is board-certified in both fields. This allows for a more integrated treatment plan. Patients benefit from surgeons who understand the precise timing needed between radiation and complex resections.
Patient Consensus: Patients note that surgeons emphasize removing at least 12 lymph nodes to ensure accurate cancer staging. They often mention feeling relieved that multidisciplinary tumor boards review every case before surgery begins. Many are surprised by how quickly they can walk after minimally invasive robotic procedures.
When consulting a surgeon in Israel for colon cancer, you should ask about their specific techniques, personal results, and post-operative support. Focus on their experience with minimally invasive methods like laparoscopy or robotic surgery, and clarify the likelihood of needing a temporary or permanent colostomy.
Bookimed Expert Insight: Data shows that top Israeli surgeons often hold dual certifications in oncology and radiotherapy, providing a more integrated treatment plan. For instance, Dr. Hubert Auala at Hadassah Medical Center is board-certified in both fields. Patients should also ask if the surgeon personally performs the procedure; at hospitals like Sourasky, senior specialists like Dr. Joseph Klauzner are highly likely to lead the surgery themselves if they provide the initial referral.
Patient Consensus: Patients emphasize the need to ask about the specific criteria for a colostomy to avoid unexpected life changes. Many note that feeling rushed is common, so they suggest asking if the surgery is truly urgent enough to skip a second opinion. They also find it helpful to know exactly who will manage their care if the lead surgeon is unavailable during recovery.
Israeli doctors manage colon cancer through integrated tumor boards that unite surgeons, oncologists, and genetic specialists. This collaborative model features weekly multidisciplinary team meetings where experts review diagnostic data. These teams custom-tailor therapy using molecular profiling for targeted biological drugs and advanced surgical techniques.
Bookimed Expert Insight: Data shows that top Israeli institutions often provide access to dual-certified experts. For example, Dr. Auala Hubert at Hadassah Medical Center holds board certifications in both oncology and radiotherapy. This allows a single specialist to oversee multiple phases of the treatment pathway, potentially reducing the time between surgical recovery and the start of radiation.
Patient Consensus: Patients note that having a dedicated case manager helps them navigate different departments for scans and chemo. Many find that genetic testing happens early, which quickly clarifies if they need standard chemotherapy or newer targeted options. Some mention that waiting for a specialist team review takes about a week unless the case is urgent.